Romosozumab (SOST) 抗体, 单克隆-Rom

Romosozumab (SOST) 抗体, 单克隆，Romosozumab (SOST) Antibody, Monoclonal，Romosozumab (SOST) 抗体, 单克隆,Romosozumab (SOST) Antibody, Monoclonal

产品名称：Romosozumab (SOST) 抗体, 单克隆-Romosozumab (SOST) Antibody, Monoclonal

产品货号：PSI-10-479-0.1mg

产品规格：0.1mg

背景资料：Romosozumab is a humanized monoclonal antibody indicated for the treatment of osteoperosis in postmenopausal women at high risk of fracture and patients who have failed in other treatments or are intolerant to other osteoperosis therapies9. Romosozumab prevents bone resorption and induces the formation of bone though it is associated with an increased risk of cardiac death, heart attack, and stroke in one study7,8. In a comparison study of post menopausal women with osteoporosis and a past fracture, romosozumab for 12 months followed by alendronic acid for 12 months was superior to alendronic acid alone for 24 months3. Romosozumab also demonstrates a faster and larger increase in bone density than teriparatide4. Romosozumab is marketed in the United States by Amgen under the brand name Evinity7. Romosozumab was granted FDA approval on April 9,2019.

保存建议：Romosozumab (SOST) 抗体, 单克隆-Romosozumab (SOST) Antibody, MonoclonalStore at -80℃

应用类型：

点击：Romosozumab (SOST) 抗体, 单克隆-Romosozumab (SOST) Antibody, Monoclonal查看更详细产品说明，更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论，请点击查看艾美捷特色产品中心。